Clearside Biomedical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLSD and other ETFs, options, and stocks.

About CLSD

Clearside Biomedical, Inc. is a biopharmaceutical company that delivers therapies to the back of the eye through the suprachoroidal space. Its SCS microinjector enables a simple, repeatable, in-office procedure to deliver treatments directly to the macula, retina, or choroid, potentially helping to preserve and improve vision in patients with serious eye diseases. 

CEO
George M. Lasezkay
CEOGeorge M. Lasezkay
Employees
32
Employees32
Headquarters
Alpharetta, Georgia
HeadquartersAlpharetta, Georgia
Founded
2011
Founded2011
Employees
32
Employees32

CLSD Key Statistics

Market cap
64.29M
Market cap64.29M
Price-Earnings ratio
-2.03
Price-Earnings ratio-2.03
Dividend yield
Dividend yield
Average volume
144.83K
Average volume144.83K
High today
$0.848
High today$0.848
Low today
$0.81
Low today$0.81
Open price
$0.826
Open price$0.826
Volume
48.33K
Volume48.33K
52 Week high
$1.65
52 Week high$1.65
52 Week low
$0.7001
52 Week low$0.7001

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own CLSD. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.